✦ LIBER ✦

PCN8: COST-UTILITY ANALYSIS OF SEVERAL SECOND-LINE CHEMOTHERAPY SCHEMES FOR PATIENTS WITH METASTATIC BREAST CANCER

✍ Scribed by CA Uyl-de Groot; N Li; M van Agthoven; P Willemse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN57 COST-UTILITY ANALYSIS OF ADJUVANT

✍ TF Cheng 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN51 Comprehensive Investigation of Adv

✍ S.A. Hurvitz; A. Guerin; M. Brammer; E. Guardino; Z.Y. Zhou; M.S. Kaminsky; E.Q. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN4 COST-UTILITY ANALYSIS OF FULVESTRAN

✍ J Ryan; M Hirsch; H Knight 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

3612 POSTER Cost Utility Analysis of Mod

✍ M.P. Mak; F.H. Souza; D.R. Nebuloni; D.F. Saragiotto; G. Castro Jr.; J. Sabbaga; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Third line chemotherapy in patients with

✍ Sue‐Anne McLachlan; Melania Pintilie; Ian F. Tannock 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 126 KB

666 - Anthracycline as second line chemo

✍ V. Delecroix; P. Fumoleau; G. Perrocheau; N. Azli; R. Féty; F. Priou; C. Maugard 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 256 KB